KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Treasury Shares (2018 - 2025)

Takeda Pharmaceutical (TAK) has 8 years of Treasury Shares data on record, last reported at $490.4 million in Q1 2025.

  • For Q1 2025, Treasury Shares rose 41.78% year-over-year to $490.4 million; the TTM value through Mar 2025 reached $490.4 million, up 41.78%, while the annual FY2025 figure was $491.1 million, 38.18% up from the prior year.
  • Treasury Shares reached $209917.6 in Q1 2023 per TAK's latest filing, down from $274426.1 in the prior quarter.
  • Across five years, Treasury Shares topped out at $274426.1 in Q1 2022 and bottomed at $92886.0 in Q1 2019.
  • Average Treasury Shares over 5 years is $174247.0, with a median of $170904.3 recorded in 2020.
  • Peak YoY movement for Treasury Shares: surged 77.42% in 2022, then tumbled 54.39% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $562.6 million in 2021, then soared by 77.42% to $998.2 million in 2022, then fell by 24.03% to $758.4 million in 2023, then crashed by 54.39% to $345.9 million in 2024, then surged by 41.78% to $490.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $490.4 million in Q1 2025, $345.9 million in Q1 2024, and $758.4 million in Q1 2023.